1. Home
  2. CLSD vs MCHX Comparison

CLSD vs MCHX Comparison

Compare CLSD & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • MCHX
  • Stock Information
  • Founded
  • CLSD 2011
  • MCHX 2003
  • Country
  • CLSD United States
  • MCHX United States
  • Employees
  • CLSD N/A
  • MCHX N/A
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • MCHX Business Services
  • Sector
  • CLSD Health Care
  • MCHX Consumer Discretionary
  • Exchange
  • CLSD Nasdaq
  • MCHX Nasdaq
  • Market Cap
  • CLSD 74.3M
  • MCHX 84.3M
  • IPO Year
  • CLSD 2016
  • MCHX 2004
  • Fundamental
  • Price
  • CLSD $0.93
  • MCHX $1.92
  • Analyst Decision
  • CLSD Strong Buy
  • MCHX
  • Analyst Count
  • CLSD 6
  • MCHX 0
  • Target Price
  • CLSD $5.33
  • MCHX N/A
  • AVG Volume (30 Days)
  • CLSD 301.0K
  • MCHX 31.7K
  • Earning Date
  • CLSD 03-11-2025
  • MCHX 03-13-2025
  • Dividend Yield
  • CLSD N/A
  • MCHX N/A
  • EPS Growth
  • CLSD N/A
  • MCHX N/A
  • EPS
  • CLSD N/A
  • MCHX N/A
  • Revenue
  • CLSD $7,703,000.00
  • MCHX $48,594,000.00
  • Revenue This Year
  • CLSD N/A
  • MCHX N/A
  • Revenue Next Year
  • CLSD $91.87
  • MCHX $4.63
  • P/E Ratio
  • CLSD N/A
  • MCHX N/A
  • Revenue Growth
  • CLSD 248.39
  • MCHX N/A
  • 52 Week Low
  • CLSD $0.80
  • MCHX $1.11
  • 52 Week High
  • CLSD $2.12
  • MCHX $2.40
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 42.76
  • MCHX 48.44
  • Support Level
  • CLSD $0.90
  • MCHX $1.88
  • Resistance Level
  • CLSD $0.97
  • MCHX $2.13
  • Average True Range (ATR)
  • CLSD 0.05
  • MCHX 0.11
  • MACD
  • CLSD 0.00
  • MCHX -0.01
  • Stochastic Oscillator
  • CLSD 24.29
  • MCHX 46.15

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

Share on Social Networks: